TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

J Vadakekolathu; C Lai; S Reeder; SE Church; T Hood; A Lourdusamy; MP Rettig; I Aldoss; AS Advani; J Godwin; MJ Wieduwilt; M Arellano; J Muth; TO Yau; F Ravandi; K Sweet; H Altmann; GA Foulds; F Stolzel; JM Middeke; M Ciciarello; A Curti; Peter Valk; Bob Löwenberg; I Gojo; M Bornhauser; JF DiPersio; JK Davidson-Moncada; S Rutella

doi:10.1182/bloodadvances.2020002512

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

J Vadakekolathu, C Lai, S Reeder, SE Church, T Hood, A Lourdusamy, MP Rettig, I Aldoss, AS Advani, J Godwin, MJ Wieduwilt, M Arellano, J Muth, TO Yau, F Ravandi, K Sweet, H Altmann, GA Foulds, F Stolzel, JM MiddekeM Ciciarello, A Curti, Peter Valk, Bob Löwenberg, I Gojo, M Bornhauser, JF DiPersio, JK Davidson-Moncada, S Rutella

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

93 Citations (Scopus)

Original language	English
Pages (from-to)	5011-5024
Number of pages	14
Journal	Blood advances
Volume	4
Issue number	20
DOIs	https://doi.org/10.1182/bloodadvances.2020002512
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1182/bloodadvances.2020002512

http://hdl.handle.net/1765/131653

Cite this

Vadakekolathu, J., Lai, C., Reeder, S., Church, SE., Hood, T., Lourdusamy, A., Rettig, MP., Aldoss, I., Advani, AS., Godwin, J., Wieduwilt, MJ., Arellano, M., Muth, J., Yau, TO., Ravandi, F., Sweet, K., Altmann, H., Foulds, GA., Stolzel, F., ... Rutella, S. (2020). TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood advances, 4(20), 5011-5024. https://doi.org/10.1182/bloodadvances.2020002512

@article{a02554e9f20444419e3286ef836abc3b,

title = "TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML",

author = "J Vadakekolathu and C Lai and S Reeder and SE Church and T Hood and A Lourdusamy and MP Rettig and I Aldoss and AS Advani and J Godwin and MJ Wieduwilt and M Arellano and J Muth and TO Yau and F Ravandi and K Sweet and H Altmann and GA Foulds and F Stolzel and JM Middeke and M Ciciarello and A Curti and Peter Valk and Bob L{\"o}wenberg and I Gojo and M Bornhauser and JF DiPersio and JK Davidson-Moncada and S Rutella",

year = "2020",

doi = "10.1182/bloodadvances.2020002512",

language = "English",

volume = "4",

pages = "5011--5024",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "20",

}

Vadakekolathu, J, Lai, C, Reeder, S, Church, SE, Hood, T, Lourdusamy, A, Rettig, MP, Aldoss, I, Advani, AS, Godwin, J, Wieduwilt, MJ, Arellano, M, Muth, J, Yau, TO, Ravandi, F, Sweet, K, Altmann, H, Foulds, GA, Stolzel, F, Middeke, JM, Ciciarello, M, Curti, A, Valk, P , Löwenberg, B, Gojo, I, Bornhauser, M, DiPersio, JF, Davidson-Moncada, JK & Rutella, S 2020, 'TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML', Blood advances, vol. 4, no. 20, pp. 5011-5024. https://doi.org/10.1182/bloodadvances.2020002512

TY - JOUR

T1 - TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

AU - Vadakekolathu, J

AU - Lai, C

AU - Reeder, S

AU - Church, SE

AU - Hood, T

AU - Lourdusamy, A

AU - Rettig, MP

AU - Aldoss, I

AU - Advani, AS

AU - Godwin, J

AU - Wieduwilt, MJ

AU - Arellano, M

AU - Muth, J

AU - Yau, TO

AU - Ravandi, F

AU - Sweet, K

AU - Altmann, H

AU - Foulds, GA

AU - Stolzel, F

AU - Middeke, JM

AU - Ciciarello, M

AU - Curti, A

AU - Valk, Peter

AU - Löwenberg, Bob

AU - Gojo, I

AU - Bornhauser, M

AU - DiPersio, JF

AU - Davidson-Moncada, JK

AU - Rutella, S

PY - 2020

Y1 - 2020

U2 - 10.1182/bloodadvances.2020002512

DO - 10.1182/bloodadvances.2020002512

M3 - Article

SN - 2473-9529

VL - 4

SP - 5011

EP - 5024

JO - Blood advances

JF - Blood advances

IS - 20

ER -